BridgeMD
New treatment option for Anesthesia, Intravenous
Official title Remifentanil Effect on Burst Suppression Ratio
ClinicalTrials.gov ID: NCT06237101
What this study is testing
What is High dose of remifentanil?
High dose of remifentanil is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for anesthesia, intravenous.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to determine whether remifentanil has a facilitating effect on the generation of burst suppression by propofol in adult patients (18-60 years) candidates for elective surgery who require remifentanil and American Society of Anesthesiology (ASA) classification I or II. The main question it aims to answer are: To determine whether remifentanil has a facilitating effect on the generation of burst suppression by propofol.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- American Society of Anesthesiology I or II
- Elective surgery of low or intermediate risk
You likely can't join if
- Neurological disease
- Psychiatric disease
- Use of psychoactive drugs or opioids
- Altered basal state of consciousness
- Allergy to propofol
- Body mass index \> 35 kg/m2
See the full eligibility criteria
- American Society of Anesthesiology I or II
- Elective surgery of low or intermediate risk
- Neurological disease
- Psychiatric disease
- Use of psychoactive drugs or opioids
- Altered basal state of consciousness
- Allergy to propofol
- Body mass index \> 35 kg/m2
- Pre-existing renal, cardiac and/or hepatic dysfunction
- Patient's refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, RM, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, RM, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.